木瓜直播

USPSTF says new findings were consistent with those of previous review

Pregnant people and those who are immunocompromised most at risk, agency warns

Longer-acting crovalimab designed for more sustained effect and less treatment burden

Indication for HIF-PH inhibitor vadadustat limited to patients already on dialysis

By 12-2 vote, members find improvement in transfusion independence outweighs risk

Agency asking its advisors if benefits outweigh risks for patients who fail on standard treatment

News, features, and commentary about cancer-related issues

Lifetime reduction in acute pain episodes should offset high upfront costs of the therapy

In a phase III trial, momelotinib reduced anemia, constitutional symptoms, and splenomegaly

Commission lays out strategies for progress by 2025 and beyond

An analysis of the ASPREE trial showed 100-mg aspirin led to more anemia events vs placebo

Results suggest a "paradigm shift" in the treatment of anemia for these patients

What effects might emerging therapies have on real-world survival?

Trial confirms higher rate of hypophosphatemia with ferric carboxymaltose